Daily non-political popular news in brief.

Diabetes drug dramatically boosts power of platinum chemotherapy

A widely used diabetes drug dramatically boosted the potency of platinum-based cancer drugs when administered together to a variety of cancer cell lines and to mice with tumors, scientists from Dana-Farber Cancer Institute report.

Read more »

Keywords: diabetes, drug, dramatically, boosts, power, platinum, chemotherapy, diabete, boost

« Previous | Next »

Similar news on "Diabetes drug dramatically boosts power of platinum chemotherapy":

1. Experimental drug boosts survival in recurrent ovarian cancer
   09-27-2007 · EurekAlert!
   An experimental drug has shown promise in extending the survival period for women with recurrent ovarian cancer whose treatment options have dwindled. Early testing data showed that pertuzumab added weeks to the lives of Stage 3 ovarian cancer patients whose disease had returned after treatment with existing chemotherapy, said a researcher from the University of Alabama at Birmingham.
   Similar news · Read more »
   
2. New treatment boosts bone healing and regrowth
   01-09-2008 · EurekAlert!
   A drug originally used to treat iron poisoning can significantly boost the body's ability to heal and regrow injured bones, according to a new study. Bone density following the new treatment more than doubled. Researchers found new blood vessel growth, necessary for bone healing, was achieved through a cell pathway.
   Similar news · Read more »
   
3. Does a component of niacin point the way to anti-aging drugs?
   02-08-2007 · EurekAlert!
   In recent years, scientists have discovered that a family of enzymes called sirtuins can dramatically extend life in organisms as diverse as yeast, worms and flies. A number of scientific groups and biotechnology companies are eagerly searching for drug candidates able to boost sirtuin activity, hoping to develop an "anti-aging" drug. Now, a new study from scientists at the Wistar Institute points to another strategy for activating sirtuins to unleash their anti-aging powers.
   Similar news · Read more »
   
4. Cisplatin is more effective than carboplatin for treating nonsmall cell lung cancer
   06-05-2007 · EurekAlert!
   Some patients with advanced nonsmall cell lung cancer have slightly higher survival rates when treated with the chemotherapy drug cisplatin than another platinum-based drug, carboplatin, according to a study in the June 6 Journal of the National Cancer Institute. The authors conclude that cisplatin chemotherapy should remain the standard of care for these patients.
   Similar news · Read more »
   
5. MIT: Flowing bubbles mimic computer
   02-08-2007 · EurekAlert!
   In work that could dramatically boost the capabilities of "lab on a chip" devices, MIT researchers have created a way to use tiny bubbles to mimic the capabilities of a computer.
   Similar news · Read more »
   
6. Mass. General leading international trial of novel breast cancer drug
   12-13-2006 · EurekAlert!
   A clinical trial of a new targeted breast cancer drug, led by physicians at Massachusetts General Hospital Cancer Center, has begun enrolling patients. The TEACH (Tykerb Evaluation After CHemotherapy) trial will investigate the experimental drug Tykerb (lapatinib) in patients with early-stage, HER2-positive breast cancer who have not been treated with Herceptin, another targeted drug used for the same type of tumor.
   Similar news · Read more »
   
7. Cetuximab may prolong survival for head and neck cancer patients
   01-18-2007 · EurekAlert!
   Preliminary findings show adding the chemotherapy drug cetuximab (brand name Erbitux) to radiation therapy and chemotherapy may help some patients with head and neck cancer live longer, according to a study presented at the plenary session of the Multidisciplinary Head and Neck Cancer Symposium, co-sponsored by the American Society for Therapeutic Radiology and Oncology, the American Society for Clinical Oncology and the American Head and Neck Society.
   Similar news · Read more »
   
8. Cancer stem cells similar to normal stem cells can thwart anti-cancer agents
   06-15-2007 · EurekAlert!
   Current cancer therapies often are thwarted because they cannot eliminate a small reservoir of multiple-drug-resistant tumor cells. Researchers at the University of Pittsburgh School of Medicine suggests that for chemotherapy to be truly effective in treating lung cancers, for example, it must be able to target a small subset of cancer stem cells, which they have shown share the same protective mechanisms as normal lung stem cells.
   Similar news · Read more »
   
9. Complete response with oblimersen combination improves survival of CLL patients
   12-09-2007 · EurekAlert!
   Relapsed chronic lymphocytic leukemia (CLL) patients who had a complete response to combination therapy that included the drug oblimersen survived significantly longer than patients treated with chemotherapy alone, a team led by researchers at the University of Texas M. D. Anderson Cancer Center reports at the 49th Annual Meeting of the American Society of Hematology.
   Similar news · Read more »
   
10. Fantastic voyage: Drug delivery by a nanoparticle
    02-13-2008 · Massachusetts Institute of Technology (MIT)
    An image portrays targeted nanoparticles delivering high doses of chemotherapy to cancer cells. A team including MIT Institute Professor Robert Langer has demonstrated the precision required to engineer a nanoparticle that is effective in targeted drug delivery.
    Similar news · Read more »